Abstract |
There has been a number of studies looking into an alternative mode of therapy for the treament of breast cancer via 4-hydroxytamoxifen (4-OHT) transdermal administration.This systematic review aims to compare the safety and efficacy of a transdermal 4-OHT local therapy and oral tamoxifen (oral-T) on the treatment of ductal carcinoma in situ breast cancer. Through a systematic search of health science databases, eligible trials were located and the end points assessed were Ki-67 labeling index, concentration of 4-OHT in breast adipose tissue (ng/g) and plasma (ng/ml). Revman 5.3 version was used to perfom the meta-analysis. Three trials were identified (n=103), while only two were included for meta analysis. The mean difference between the two studies included were 0.40 and -10.58. Overall the I2 value was 89.0%, (Tau2 =53.86) and the differences between the two trials were statistically significant p=0.002. The meta analysis of the randomized controlled trials showed that the use of local transdermal therapy of 4-OHT gel is more safer than oral-T. However, due to the limited number of studies, the potential use of 4-OHT topical transdermal therapy for the treatment of breast cancer could not be concluded for healthcare professionals.
|
Authors | Usha Sundralingam, Tahir Mehmood Khan, Sumita Elendran, Saravanan Muniyandy, Uma D Palanisamy |
Journal | Pakistan journal of pharmaceutical sciences
(Pak J Pharm Sci)
Vol. 32
Issue 3
Pg. 1121-1128
(May 2019)
ISSN: 1011-601X [Print] Pakistan |
PMID | 31278729
(Publication Type: Journal Article, Meta-Analysis, Systematic Review)
|
Chemical References |
- Antineoplastic Agents
- Tamoxifen
- afimoxifene
|
Topics |
- Administration, Cutaneous
- Administration, Oral
- Antineoplastic Agents
(administration & dosage, pharmacokinetics)
- Breast Neoplasms
(drug therapy)
- Carcinoma, Intraductal, Noninfiltrating
(drug therapy)
- Female
- Humans
- Randomized Controlled Trials as Topic
- Tamoxifen
(administration & dosage, analogs & derivatives, pharmacokinetics, pharmacology)
|